As of 2025-04-19, the Fair Value of Vir Biotechnology Inc (VIR) is -19.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.50 USD, the upside of Vir Biotechnology Inc is -446.00%.
With the market price of 5.50 USD and our fair value calculation, Vir Biotechnology Inc (VIR) is not a good investment. Investing in VIR stocks now will result in a potential loss of 446.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -298.70 | 528.60 | 515.80 | -615.06 | -521.96 | -78.26 |
| YoY growth | -70.98% | 276.97% | -2.42% | -219.24% | 15.14% | -0.11% |
| Market Cap (mil) | 754.27 |
| P/E | |
| Forward P/E |
| EPS | -3.81 |
| Avg earnings growth rate | -0.11% |
| TTM earnings | -521.96 |